Would you ever think that the increase in food costs could ever be attributed to the survival of that pesky summer time picnic guest, the bee? Penny Stock BeesFree, Inc. (OTCBB: BEES), a technology company focused on solutions for beekeeper communities globally, believes its come up with a patent-pending proprietary technology that provides a solution for Colony Collapse Disorder (CCD).
CCD has been wiping out almost 30% of bee colonies annually since 2006. BEES research and development facilities in Rome, Italy have been testing which factors adversely affect honey bees health and to improve the overall understanding of CCD related issues. BEES has developed an innovative integrated approach meant to mitigate the effects of CCD and possibly even preventing CCD,a tremendous problem that can cause severe devastation to the world’s crop and food supply, to happen altogether.
Globally, Honey Bee decline and CCD has been estimated to cost $5.7 billion per year. In the U.S., more than $15 billion in crops are pollinated by Honey Bees which also produce roughly $150 million in honey annually. BEES patent-pending solution, The Beespenser, integrates a simple-to-use dispenser and a proprietary soluble-in-water preparation consisting of several specific agents such as:
- antimicrobial agents and compounds to fight the IIV Virus and its interaction with Nosema
- components to contrast neonicotinoids side effects on bees
- nutrients and antioxidants
The Beespenser is powered with DC batteries rechargeable by a small solar panel, placed amongst beehives in order to be easily accessible to bees.
According to 8-K filed January 30, 2012 with the SEC:
BEES, prior to December 16, 2011, was a “shell company”, as defined by the Securities and Exchange Commission, without material assets or activities. The records prior to the merger stand as the Financial Statements for BEES which were last filed for the quarter ended September 30, 2011 and can be reviewed here.
As of December 16, 2011, there were 16,150,000 shares of Common Stock issued and outstanding and 200,000,000 shares of Common Stock authorized. BEES will most likely focus its attention on Argentina, the world’s largest exporter and second largest producer of honey behind China, with exports of honey worth more than $200 million in 2010. BEES stated that they do not intend to market their products in the U.S. for at least 12 months.
BEES Competitive Advantages
- Low Market Entry Cost: BEES found a cheap avenue for market entry by focusing on marketing and promotions at both the local and regional levels through bee keeping communities
- Immediate Access to Products: By using wholesalers on a revenue share model, retail networks will have immediate access to products
- Effective Marketing Strategy: BEES understands as a company that the key to its success is dependent on education (the more bee keepers can see profitability in a turnkey solution to CCD, the sooner the dispensers and disposable dispensers will be convertible to revenue for the company)
- Steady Cash Flow: The BEES business model is based on renewable revenue in the replacement, every four months, of their anti-microbial agents and chemical components contained in their nebulizer, thus maintaining steady cash flow.
For all of these reasons, BEES should be able to penetrate their niche marketplace. The company has tremendous growth potential and the stock could potentially move up the charts as well. BEES is currently thinly traded at $3.05 per share on OTCBB.Share